The Intellectual property related to Lipid Nanoparticles in Drug Delivery has increased at a CAGR of ~10%, in the last two decades, claims Roots Analysis
LONDON, Aug. 10, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape" report to its list of offerings.
- With increasing research and development efforts, use of lipid nanoparticles in therapeutics has the potential to revolutionize drug delivery and address unmet medical needs.
- It is worth mentioning that the majority of patent families (41%) have more than 10 years left for expiration.
- Further, other keywords that were prominent include composition, delivery, drug and lipid.
- Majority of the innovations are focused on different methods of formulations and compositions of lipid nanoparticles used in drug delivery.